Ascending cholangitis cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]
Overview
Overview
Early ERCP is considered safe as well as cost-effective in the treatment of mild to moderate ascending cholangitis
Cost effectiveness of therapy for ascending cholangitis
Cost effectiveness of therapy for ascending cholangitis
According to some studies, early ERCP is considered safe as well as cost effective in the treatment of mild to moderate ascending cholangitis. It reduces the duration of hospital stay and antibiotics are needed for fewer days thus making it a cost effective intervention[1]
References
References
- ↑ Alper, Emrah; Unsal, Belkis; Buyraç, Zafer; Baydar, BehlüL.; Aslan, Fatih; Akça, Serdar; Ustundag, Yucel (2011). “Sa1520 Early ERCP Is Safe and Cost-Effective in the Treatment of Mild to Moderate Acute Cholangitis”. Gastrointestinal Endoscopy. 73 (4): AB195. doi:10.1016/j.gie.2011.03.254. ISSN 0016-5107.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH